Olema Oncology to Present at Jefferies Healthcare Conference

Rhea-AI Summary

Olema Pharmaceuticals, a clinical-stage biopharmaceutical company focused on women’s cancers, announced that CEO Sean P. Bohen will participate in a fireside chat at the Jefferies Healthcare Conference on June 9, 2022, at 8:30 a.m. ET. The event will be accessible through a live webcast on Olema’s website, which will remain available for 14 days post-event.

Olema’s lead candidate, OP-1250, is undergoing clinical trials for treating ER-positive, HER2-negative breast cancer.

SAN FRANCISCO, May 24, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced that Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 8:30 a.m. ET.

A live webcast of this presentation may be accessed under the Investors & Media section of Olema’s website (www.olema.com) and will be archived for 14 days.

About Olema Oncology 
Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers. Olema’s lead product candidate, OP-1250, is an orally-available small molecule with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). It is currently being evaluated as a single agent in an ongoing Phase 1/2 clinical trial, and in Phase 1b combination with palbociclib, in patients with recurrent, locally advanced, or metastatic ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema is headquartered in San Francisco and has operations in Cambridge, Massachusetts.

FAQ

What event will Olema Pharmaceuticals participate in on June 9, 2022?

Olema Pharmaceuticals will participate in a fireside chat at the Jefferies Healthcare Conference.

Who is the CEO of Olema Pharmaceuticals?

Sean P. Bohen is the CEO of Olema Pharmaceuticals.

What is Olema Pharmaceuticals' lead product candidate?

Olema's lead product candidate is OP-1250, designed to treat women’s cancers.

Where can I access the webcast of Olema's event?

The webcast of Olema's event can be accessed on their website under the Investors & Media section.

How long will the webcast from the Jefferies Healthcare Conference be available?

The webcast will be archived and available for 14 days.